Share this:

Nov 25, 2013 · Leave a Reply

Mayo Clinic first in U.S. to test stem cell use in clinical trial for pediatric congenital heart disease

By Center for Regenerative Medicine @centerforregmedmc

Mayo Clinic recently announced the first stem cell-based clinical trial for congenital heart disease. The clinical trial aims to determine how stem cells derived from autologous umbilical cord blood can help children with Hypoplastic Left Heart Syndrome, a rare defect where the left side of the heart is critically underdeveloped.

Read the full news release and watch a video describing the research:

Tags: HLHS, Mayo Clinic, research, stem cells, Timothy Nelson, Uncategorized

Please login or become a member to post a comment.

Contact Us · Privacy Policy